Financhill
Back

Palisade Bio Quote, Financials, Valuation and Earnings

Palisade Bio Price Quote

$1.76
+0.01 (+-2.22%)
(Updated: December 21, 2024 at 5:41 AM ET)

Palisade Bio Key Stats

Sell
27
Palisade Bio (PALI) is a Sell

Day range:
$1.75 - $1.86
52-week range:
$1.38 - $22.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.41%

Volume:
119.5K
Avg. volume:
2.5M
1-year change:
-79.95%
Market cap:
$2.7M
Revenue:
$250K
EPS:
$-13.99

How Much Does Palisade Bio Make?

Data Unavailable

Is Palisade Bio Growing As A Company?

Data Unavailable

Palisade Bio Stock Price Performance

  • Did Palisade Bio Stock Go Up Last Month?
    Palisade Bio share price went down by -28.28% last month
  • Did PALI's Share Price Rise Over The Last Year?
    PALI share price fell by -79.95% over the past 1 year

What Is Palisade Bio 52-Week High & Low?

Palisade Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Palisade Bio?

Data Unavailable

Is Palisade Bio Cash Flow Positive?

Data Unavailable

Palisade Bio Return On Invested Capital

Data Unavailable

Palisade Bio Earnings Date & Stock Price

  • What Is Palisade Bio's Stock Price Today?
    A single share of PALI can be purchased today for 1.75
  • What Is Palisade Bio’s Stock Symbol?
    Palisade Bio trades on the nasdaq under the ticker symbol: PALI
  • When Is Palisade Bio’s Next Earnings Date?
    The next quarterly earnings date for Palisade Bio is scheduled on December 22, 2024
  • When Is PALI's next ex-dividend date?
    Palisade Bio's next ex-dividend date is December 22, 2024
  • How To Buy Palisade Bio Stock?
    You can buy Palisade Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Palisade Bio Competitors

  • Who Are Palisade Bio's Competitors?
    Below is a list of companies who compete with Palisade Bio or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Palisade Bio Dividend Yield

Data Unavailable

Palisade Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 30.85%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable